๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด๋ž€?

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ(Glucosamine)์€ ์งˆ์†Œ๋ฅผ ํ•จ์œ ํ•˜๋Š” ์•„๋ฏผ(Amine)๊ณผ ํฌ๋„๋‹น(ํ˜ˆ๋‹น)์ด ๊ฒฐํ•ฉ๋˜์–ด ์ฒด๋‚ด์—์„œ ์ƒ์„ฑ๋˜๋Š” ์ฒœ์—ฐ ๋ฌผ์งˆ์ž…๋‹ˆ๋‹ค. ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์—ฐ๊ณจ, ํž˜์ค„, ์ธ๋Œ€๋ฅผ ๊ตฌ์กฐ์ ์œผ๋กœ ์ง€์ง€ํ•˜๋Š” ๋ฌผ์งˆ์ธ ๊ธ€๋ฆฌ์ฝ”์‚ฌ๋ฏธ๋…ธ๊ธ€๋ฆฌ์นธ(Glycosaminoglycan)์˜ ์ƒ์„ฑ์„ ์ด‰์ง„ํ•ฉ๋‹ˆ๋‹ค.

์—ผ์ฆ ์–ต์ œ

50์—ฌ ๋…„ ์ „ ์„ธ๊ณ„๋ณด๊ฑด๊ธฐ๊ตฌ(World Health Organization, WHO)์—์„œ ์ˆ˜ํ–‰ํ•œ ํš๊ธฐ์ ์ธ ์—ฐ๊ตฌ์—์„œ ์‚ฌ๋žŒ์€ ๋‚˜์ด๊ฐ€ ๋“ค์ˆ˜๋ก ์ถฉ๋ถ„ํ•œ ์–‘์˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์„ ์ƒ์‚ฐํ•˜๋Š” ๋Šฅ๋ ฅ์ด ์ €ํ•˜๋˜๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค. 

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด ์ถฉ๋ถ„ํ•˜์ง€ ์•Š์œผ๋ฉด ์—ฐ๊ณจ์€ ์ ค ๊ฐ™์€ ํŠน์„ฑ๊ณผ ์ถฉ๊ฒฉ์„ ํก์ˆ˜ํ•˜๋Š” ๊ธฐ๋Šฅ์„ ์žƒ์Šต๋‹ˆ๋‹ค. ๊ธ€๋ฆฌ์ฝ”์‚ฌ๋ฏธ๋…ธ๊ธ€๋ฆฌ์นธ์€ ์—ฐ๊ณจ์˜ ๊ตฌ์กฐ์  ๊ณจ๊ฒฉ ์—ญํ• ์„ ํ•˜๋ฉฐ ์—ฐ๊ณจ ๋ฐ ๊ธฐํƒ€ ๊ด€์ ˆ ๊ตฌ์„ฑ ์š”์†Œ์˜ ์ˆ˜๋ถ„ ํ•จ๋Ÿ‰์„ ๋†’์€ ์ˆ˜์ค€์œผ๋กœ ์œ ์ง€ํ•˜๋Š” ๋ฐ ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค. ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด ์ถฉ๋ถ„ํ•˜์ง€ ์•Š์œผ๋ฉด ๊ด€์ ˆ์€ ํ‡ดํ™”(๋ถ„ํ•ด)๋˜๊ธฐ ์‹œ์ž‘ํ•ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์—ผ์ฆ ๊ณผ์ •์—๋„ ์ผ์ • ์ •๋„ ๊ด€์—ฌํ•ฉ๋‹ˆ๋‹ค.

๊ด€์ ˆ ๊ฑด๊ฐ•๊ณผ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์˜ ์—ฐ๊ด€์„ฑ์ด ์ž…์ฆ๋œ ํ›„, ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์— ๋Œ€ํ•œ ์ง‘์ค‘์ ์ธ ์—ฐ๊ตฌ๊ฐ€ ์ด๋ฃจ์–ด์ง์— ๋”ฐ๋ผ ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ๊ฐœ์„ ํ•˜๋ ค๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์„ ๋ณด์ถฉํ•ด์•ผ ํ•˜๋Š” ์ด์œ ์™€ ์ด๋•Œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด ์ˆ˜ํ–‰ํ•˜๋Š” ์—ญํ• ์ด ๋ฐํ˜€์ง€๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์ „ ์„ธ๊ณ„์˜ ๋งŽ์€ ์˜๋ฃŒ ๊ธฐ๊ด€์—์„œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ๊ด€์ ˆ ๊ฑด๊ฐ• ๋ฌธ์ œ๋ฅผ ํ•ด๊ฒฐํ•˜๋Š” ๋ฐ ๊ฐ€์žฅ ํšจ๊ณผ์ ์ธ ์ˆ˜๋‹จ์œผ๋กœ ๊ถŒ์žฅ๋˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

ํšจ๋Šฅ

๊ด€์ ˆ ๊ฑด๊ฐ• ์ฆ์ง„

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ(Glucosamine sulfate)์€ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์˜ ๊ฐ€์žฅ ์šฐ์ˆ˜ํ•œ ํ˜•ํƒœ์ด๋ฉฐ ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ์ฆ์ง„ํ•˜๋Š” ์ค‘์š”ํ•œ ๋ณด์ถฉ์ œ ์„ฑ๋ถ„์ž…๋‹ˆ๋‹ค. ์ธ๊ฐ„์„ ๋Œ€์ƒ์œผ๋กœ ํ•œ ๋‹ค์–‘ํ•œ ์ด์ค‘๋งน๊ฒ€ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ํ†ต์ฆ, ๊ด€์ ˆ ๊ธฐ๋Šฅ ์ง€์ˆ˜, ์—ฐ๊ณจ ๊ฑด๊ฐ• ์ƒํƒœ์— ๋Œ€ํ•œ ํ˜ˆ์•ก ์ง€ํ‘œ๋ฅผ ํฌ๊ฒŒ ๊ฐœ์„ ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋Œ€๋ถ€๋ถ„์˜ ๊ฒฝ์šฐ ์ด๋Ÿฌํ•œ ํšจ๋Šฅ์€ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ ์„ญ์ทจ๋ฅผ ์‹œ์ž‘ํ•œ ์ง€ 2-4์ฃผ ํ›„์— ๋‚˜ํƒ€๋‚ฉ๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ์ผ๋ถ€ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์„ ์˜ค๋ž˜ ์„ญ์ทจํ• ์ˆ˜๋ก ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ๊ฐœ์„ ํ•˜๋Š” ํšจ๊ณผ๊ฐ€ ๋†’์•„์งˆ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

3๋…„์ด๋ผ๋Š” ์˜ค๋žœ ๊ธฐ๊ฐ„์— ๊ฑธ์ณ 2๊ฑด์˜ ์œ„์•ฝ ๋Œ€์กฐ๊ตฐ ์ž„์ƒ์‹œํ—˜์ด ์ˆ˜ํ–‰๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ์‹ ๋ขฐ์„ฑ์ด ์ƒ๋‹นํžˆ ๋†’์€ ์ด ๋‘ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์„ ๋ณด์ถฉํ•œ ๊ทธ๋ฃน์€ ์—‘์Šค๋ ˆ์ด ๋ฐ ์ž„์ƒ ํ‰๊ฐ€ ๊ฒฐ๊ณผ๊ฐ€ ๊ฐœ์„ ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ์ด๋Š” ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์ด ๊ด€์ ˆ์˜ ๋…ธํ™” ๋˜๋Š” ๋ฌผ๋ฆฌ์  ์ŠคํŠธ๋ ˆ์Šค๋กœ ์ธํ•œ ์—ฐ๊ณจ ํŒŒ๊ดด์˜ ์ง„ํ–‰์„ ๋Šฆ์ถœ ์ˆ˜ ์žˆ์Œ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ์ด ์—ฐ๊ตฌ์—์„œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ ์„ญ์ทจ ๊ทธ๋ฃน์€ ๋ณด์ถฉ์„ ์ค‘๋‹จํ•œ ์ง€ 5๋…„์ด ์ง€๋‚œ ํ›„์—๋„ ์ด ๊ด€์ ˆ ๊ต์ฒด ํšŸ์ˆ˜๊ฐ€ ํ˜„์ €ํžˆ ๊ฐ์†Œํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

๋ถ€์ƒ ๋ฐฉ์ง€ ๋ฐ ํšŒ๋ณต

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ํŠนํžˆ ์ถ•๊ตฌ, ๋ฏธ์‹์ถ•๊ตฌ, ๋†๊ตฌ ๋˜๋Š” ์ฒด์ค‘ ๋ถ€ํ•˜๊ฐ€ ๊ฐ€ํ•ด์ง€๋Š” ์Šคํฌ์ธ  ์ข…๋ชฉ์˜ ์„ ์ˆ˜๋‚˜ ๋‹ฌ๋ฆฌ๊ธฐ ์„ ์ˆ˜์™€ ๊ฐ™์ด ๊ด€์ ˆ์— ๋ฌด๋ฆฌ๊ฐ€ ๊ฐ€๋Š” ์šด๋™์„ ์ˆ˜์˜ ์—ฐ๊ณจ ํ‡ดํ–‰์„ ์˜ˆ๋ฐฉํ•˜๋Š” ์ˆ˜๋‹จ์œผ๋กœ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋˜ํ•œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ๊ฒฝ๋ฏธํ•œ ๊ธ‰์„ฑ ๊ด€์ ˆ ์—ผ์ขŒ ๋ฐ ์ขŒ์ƒ์˜ ํšŒ๋ณต์„ ๋•๋Š” ๋ฐ ๋„์›€์ด ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํ•œ ์ด์ค‘๋งน๊ฒ€ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด 3๊ฐœ์›” ๋™์•ˆ ๋งค์ผ 1,500mg ๋˜๋Š” 3,000mg์˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์„ ์„ญ์ทจํ•œ ์ถ•๊ตฌ ์„ ์ˆ˜๋Š” ์—ฐ๊ณจ ์ƒ์„ฑ์— ๋Œ€ํ•œ ํ˜ˆ์•ก ์ง€ํ‘œ๊ฐ€ ์ฆ๊ฐ€ํ•˜๊ณ  ์—ฐ๊ณจ ํŒŒ๊ดด๋ฅผ ๋‚˜ํƒ€๋‚ด๋Š” ๋น„์œจ์ด ๊ฐ์†Œํ•œ ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋Š” ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์ด ์—ฐ๊ณจ์„ ๋ณดํ˜ธํ•˜๋Š” ์ž‘์šฉ์„ ํ•  ์ˆ˜ ์žˆ์Œ์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค.

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด ํ•จ์œ ๋œ ์‹ํ’ˆ

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์‹ํ’ˆ์„ ํ†ตํ•ด ์„ญ์ทจํ•  ์ˆ˜ ์—†๊ณ  ๋ณด์ถฉ์ œ๋ฅผ ํ†ตํ•ด์„œ๋งŒ ์–ป์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋ณด์ถฉ์ œ์— ์‚ฌ์šฉ๋˜๋Š” ๋Œ€๋ถ€๋ถ„์˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์ƒˆ์šฐ, ๋ฐ”๋‹ท๊ฐ€์žฌ, ๊ฒŒ์˜ ์™ธ๊ณจ๊ฒฉ์„ ์ด๋ฃจ๋Š” ์„ฑ๋ถ„์ธ ํ‚คํ‹ด(Chitin)์—์„œ ์ถ”์ถœ๋ฉ๋‹ˆ๋‹ค. ๋ฏธ์ƒ๋ฌผ์„ ์ด์šฉํ•˜์—ฌ ์˜ฅ์ˆ˜์ˆ˜ ์„ฑ๋ถ„์„ ๋ฐœํšจ์‹œ์ผœ ๋งŒ๋“  ์‹๋ฌผ์„ฑ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ๋ณด์ถฉ์ œ๋„ ์ถœ์‹œ๋ฉ๋‹ˆ๋‹ค.

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์˜ ์ข…๋ฅ˜์™€ ์ตœ๊ณ ์˜ ํ˜•ํƒœ

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ 300๊ฑด์ด ๋„˜๋Š” ์—ฐ๊ตฌ์™€ 30๊ฑด์˜ ์ด์ค‘๋งน๊ฒ€ ์ž„์ƒ์‹œํ—˜์„ ํ†ตํ•ด ๊ด‘๋ฒ”์œ„ํ•˜๊ฒŒ ์กฐ์‚ฌ๋˜๋ฉฐ ํšจ๋Šฅ์ด ํ™•์ธ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ์—ฌ๋Ÿฌ ์œ ํ˜•์˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์ค‘์—์„œ ์„ ํ˜ธ๋˜๋Š” ํ˜•ํƒœ์ด๋ฉฐ ์ „ ์„ธ๊ณ„์ ์œผ๋กœ ์ˆ˜๋ฐฑ๋งŒ ๋ช…์— ๋‹ฌํ•˜๋Š” ์‚ฌ๋žŒ๋“ค์ด ์„ญ์ทจํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. 

70๊ฐœ๊ตญ ์ด์ƒ์—์„œ ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ์ง€์›ํ•˜๋Š” ๋ณด์ถฉ์ œ๋กœ ๋“ฑ๋ก๋œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ๋†€๋ผ์šด ํŠน์„ฑ์„ ๋‚˜ํƒ€๋‚ด๋Š” ๊ฒƒ์œผ๋กœ ์ž…์ฆ๋˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์˜ ํก์ˆ˜ ๋ฐ ๋ถ„ํฌ๋ฅผ ์ง‘์ค‘์ ์œผ๋กœ ์กฐ์‚ฌํ•œ ์ž„์ƒ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์˜ ํก์ˆ˜์œจ์ด ์ตœ๋Œ€ 98%์— ์ด๋ฅด๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ์ฒด๋‚ด์— ํก์ˆ˜๋˜๋ฉด ์ฃผ๋กœ ๊ด€์ ˆ ์กฐ์ง์„ ํ‘œ์ ์œผ๋กœ ์‚ผ์•„ ์—ฐ๊ณจ, ์ธ๋Œ€, ํž˜์ค„ ์ƒ์„ฑ์„ ๋•์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋Š” ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์ด ๊ด€์ ˆ ๊ฑด๊ฐ•์— ์ค‘์š”ํ•œ ์—ญํ• ์„ ์ˆ˜ํ–‰ํ•œ๋‹ค๋Š” ์ ์„ ์‹œ์‚ฌํ•ฉ๋‹ˆ๋‹ค.

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ(Glucosamine hydrochloride)์˜ ์ฃผ์š” ํšจ๋Šฅ ์ค‘ ํ•˜๋‚˜๋Š” ๊ธ€๋ฆฌ์ฝ”์‚ฌ๋ฏธ๋…ธ๊ธ€๋ฆฌ์นธ์˜ ์ƒ์„ฑ์„ ์ด‰์ง„ํ•˜๋Š” ๊ฒƒ์ด๋ฏ€๋กœ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ์„ ์‚ฌ์šฉํ•  ๋•Œ ํ™ฉ์ด ๋ถ€์กฑํ•˜๋ฉด ๊ธ€๋ฆฌ์ฝ”์‚ฌ๋ฏธ๋…ธ๊ธ€๋ฆฌ์นธ์˜ ํ•ฉ์„ฑ์ด ๊ฐ์†Œํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. 

๋”ฐ๋ผ์„œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ์€ ์ด์ฒ˜๋Ÿผ ์ค‘์š”ํ•œ ์š”์†Œ์ธ ํ™ฉ์ด ์—†๊ธฐ ๋•Œ๋ฌธ์— ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ๊ณผ ๋™์ผํ•œ ์ˆ˜์ค€์˜ ์šฐ์ˆ˜ํ•œ ์ž„์ƒ ๊ฒฐ๊ณผ๋ฅผ ๋‚˜ํƒ€๋‚ผ ๊ฐ€๋Šฅ์„ฑ์ด ๋‚ฎ์Šต๋‹ˆ๋‹ค.

์—ฌ๋Ÿฌ ์ด์ค‘๋งน๊ฒ€ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ์ด ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ๊ฐœ์„ ํ•˜๋Š” ํšจ๊ณผ๋Š” ์œ„์•ฝ๊ณผ ์ฐจ์ด๊ฐ€ ์—†๋Š” ์ˆ˜์ค€์ธ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ํ•œ ์ด์ค‘๋งน๊ฒ€, ์œ„์•ฝ ๋Œ€์กฐ๊ตฐ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ์ด ํ”ผํ—˜์ž์˜ ๋ฌด๋ฆŽ ๊ฑด๊ฐ•์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์„ ์กฐ์‚ฌํ–ˆ์Šต๋‹ˆ๋‹ค. ํ”ผํ—˜์ž๋“ค์€ 500mg์˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ ๋˜๋Š” ์œ„์•ฝ์„ 10์ฃผ ๋™์•ˆ ๋งค์ผ 3ํšŒ ํˆฌ์—ฌ๋ฐ›์•˜์Šต๋‹ˆ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ, ์‹คํ—˜๊ตฐ๊ณผ ๋Œ€์กฐ๊ตฐ ์‚ฌ์ด์˜ ์ฐจ์ด๋Š” ํ†ต๊ณ„์ ์œผ๋กœ ์œ ์˜๋ฏธํ•˜์ง€ ์•Š์€ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ์„ ์‚ฌ์šฉํ•œ ๋Œ€๊ทœ๋ชจ ์—ฐ๊ตฌ์—์„œ๋Š” ๋ฌด๋ฆŽ ํ†ต์ฆ์ด ์žˆ๊ณ  ๊ด€์ ˆ ๊ธฐ๋Šฅ์ด ๋‚˜์œ 1,583๋ช…์˜ ํ™˜์ž๋ฅผ ๋ฌด์ž‘์œ„๋กœ ๊ทธ๋ฃน์— ๋ฐฐ์ •ํ•˜์—ฌ 24์ฃผ ๋™์•ˆ ๋งค์ผ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ 1,500mg, ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ 1,200mg, ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ 1,500mg๊ณผ ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ 1,200mg, ์…€๋ ˆ์ฝ•์‹œ๋ธŒ(Celecoxib) 200mg ๋˜๋Š” ์œ„์•ฝ์„ ๊ฐ ๊ทธ๋ฃน์— ํˆฌ์—ฌํ–ˆ์Šต๋‹ˆ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ, ์—ฐ๊ตฌ ์‹œ์ž‘ ์‹œ ์ค‘๋“ฑ๋„ ๋‚ด์ง€ ์ค‘์ฆ์˜ ํ†ต์ฆ์ด ์žˆ๋˜ ํ™˜์ž๋Š” ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ๊ณผ ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ์„ ํ•จ๊ป˜ ์„ญ์ทจํ•œ ๊ฒฝ์šฐ ์œ„์•ฝ์— ๋น„ํ•ด ๋ฐ˜์‘๋ฅ ์ด ์œ ์˜๋ฏธํ•˜๊ฒŒ ๋” ๋†’์•˜์Šต๋‹ˆ๋‹ค(79.2% ๋Œ€ 54.3%). ํ•˜์ง€๋งŒ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ ๋˜๋Š” ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ์„ ๋‹จ๋…์œผ๋กœ ์„ญ์ทจํ•œ ๊ทธ๋ฃน์€ ์œ„์•ฝ๊ตฐ๊ณผ ๋น„๊ตํ•ด ํšจ๊ณผ๋ฅผ ๋ณด์ง€ ๋ชปํ–ˆ์Šต๋‹ˆ๋‹ค.

N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ

N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ(N-acetylglucosamine, NAG)์€ ๋ถ„์ž ๊ตฌ์กฐ์ƒ ํ™ฉ ๋ถ„์ž ๋Œ€์‹  ์•„์„ธํŠธ์‚ฐ ๋ถ„์ž์˜ ์ผ๋ถ€๊ฐ€ ๋ถ€์ฐฉ๋˜์–ด ์žˆ๋‹ค๋Š” ์ ์—์„œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ๊ณผ ๋‹ค๋ฆ…๋‹ˆ๋‹ค. ์ด ๋•Œ๋ฌธ์— N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ๊ณผ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ์ฒด๋‚ด์—์„œ ๋‹ค๋ฅด๊ฒŒ ์ฒ˜๋ฆฌ๋ฉ๋‹ˆ๋‹ค. ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์‰ฝ๊ฒŒ ํก์ˆ˜๋˜์ง€๋งŒ N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ๊ทธ๋Ÿฌ์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์ธ์ฒด๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์€ ์—ฌ๋Ÿฌ ๊ฐ€์ง€ ์ด์œ ๋กœ N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์„ ์ž˜ ํก์ˆ˜ํ•˜์ง€ ๋ชปํ•ฉ๋‹ˆ๋‹ค.

  • N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์žฅ๋‚ด ์„ธ๊ท ์— ์˜ํ•ด ๋น ๋ฅด๊ฒŒ ์†Œํ™”๋ฉ๋‹ˆ๋‹ค.
  • N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์žฅ์—์„œ ์‹์ด์„ฑ ๋ ‰ํ‹ด(Lectin)๊ณผ ๊ฒฐํ•ฉํ•˜์—ฌ ๋ ‰ํ‹ด-NAG ๋ณตํ•ฉ์ฒด๋ฅผ ์ด๋ฃจ๋Š”๋ฐ ์ด ๋ฌผ์งˆ์€ ๋Œ€๋ณ€์œผ๋กœ ๋ฐฐ์„ค๋ฉ๋‹ˆ๋‹ค.
  • N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์˜ ์ƒ๋‹น ๋ถ€๋ถ„์€ ์žฅ ์„ธํฌ์—์„œ ๋Œ€์‚ฌ๋ฉ๋‹ˆ๋‹ค.

์ด๋Ÿฌํ•œ ํก์ˆ˜ ๋ฌธ์ œ ์™ธ์—๋„ ๊ด€์ ˆ ์กฐ์ง์€ N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์„ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ๋งŒํผ ์ž˜ ํ™œ์šฉํ•˜์ง€ ๋ชปํ•ฉ๋‹ˆ๋‹ค. N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์ด๋Ÿฌํ•œ ํก์ˆ˜ ๋ฐ ํ™œ์šฉ ๋ฌธ์ œ ๋•Œ๋ฌธ์— ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ๊ฐœ์„ ํ•˜๋Š” ํšจ๊ณผ๊ฐ€ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ๊ณผ ๋™์ผํ•  ๊ฐ€๋Šฅ์„ฑ์ด ๊ฑฐ์˜ ์—†์Šต๋‹ˆ๋‹ค. N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์„ ํŒ๋งคํ•˜๋Š” ์—…์ฒด์—์„œ๋Š” N-์•„์„ธํ‹ธ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ๊ฐœ์„ ํ•˜๋Š” ๋ฐ ๋” ํšจ๊ณผ์ ์ธ ํ˜•ํƒœ์˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์ด๋ผ๊ณ  ์ฃผ์žฅํ•˜์ง€๋งŒ, ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋Š” ์ด๋Ÿฌํ•œ ์ฃผ์žฅ์„ ๋’ท๋ฐ›์นจํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

์šฉ๋Ÿ‰

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์˜ ํ‘œ์ค€ ์„ญ์ทจ๋Ÿ‰์€ ํ•˜๋ฃจ 1,500mg์ด๋ฉฐ, ๋งค์ผ ๋‹จํšŒ ์„ญ์ทจํ•˜๋ฉด ๋” ์ข‹์€ ๊ฒฐ๊ณผ๋ฅผ ์–ป์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋˜ํ•œ ์šด๋™์„ ์ˆ˜๋‚˜ ๊ด€์ ˆ ๋งˆ๋ชจ๊ฐ€ ์‹ฌํ•œ ์ด๋“ค์€ ์—ฐ๊ณจ ๊ฑด๊ฐ•์„ ์œ„ํ•ด ์„ญ์ทจ๋Ÿ‰์„ 3,000mg์œผ๋กœ ๋Š˜๋ ค์•ผ ํ•  ์ˆ˜๋„ ์žˆ์Šต๋‹ˆ๋‹ค.

๋ถ€์ž‘์šฉ๊ณผ ์•ˆ์ „์„ฑ

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์€ ์•ˆ์ „์„ฑ์ด ํƒ์›”ํ•œ ๊ฒƒ์œผ๋กœ ์ž…์ฆ๋˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค ๋ถ€์ž‘์šฉ์€ ์œ„์•ฝ๊ณผ ์ฐจ์ด๊ฐ€ ๋‚˜์ง€ ์•Š๊ณ , ๋“œ๋ฌผ๊ฒŒ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒฝ์šฐ์—๋„ ๊ฐ€๋ฒผ์šด ์œ„์žฅ ์ž๊ทน ์ •๋„์— ๊ทธ์น˜๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค.

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ๊ณผ ์ฝ˜๋“œ๋กœ์ด์นœ 

๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ(Chondroitin sulfate)๊ณผ ํ•จ๊ป˜ ์–ธ๊ธ‰๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ๊ด‘๋ฒ”์œ„ํ•œ ์ž„์ƒ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ๋งŒ์ด ๋…๋ฆฝํ˜• ์ œ์ œ๋กœ ์‚ฌ์šฉ๋  ๋•Œ ์ผ๊ด€์ ์ธ ์ž„์ƒ์  ํšจ๊ณผ๋ฅผ ๋ณด์ธ ๊ฒƒ์œผ๋กœ ์ž…์ฆ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ๋งŽ์€ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ(Glucosamine Hydrochlorid)๊ณผ ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ์„ ๋ณ‘์šฉํ•  ๊ฒฝ์šฐ ํšจ๊ณผ์ ์ด๋ฉฐ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์„ ๋‹จ๋…์œผ๋กœ ์‚ฌ์šฉํ•  ๋•Œ ์ž„์ƒ์  ํšจ๊ณผ๊ฐ€ ๊ฐ€์žฅ ์šฐ์ˆ˜ํ•ฉ๋‹ˆ๋‹ค.

๋˜ํ•œ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ๊ณผ ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ์„ ๋ณ‘์šฉํ•ด๋„ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์„ ๋‹จ๋…์œผ๋กœ ์‚ฌ์šฉํ•  ๋•Œ๋ณด๋‹ค ์œ ์˜๋ฏธํ•˜๊ฒŒ ๋” ํšจ๊ณผ์ ์ด์ง€๋Š” ์•Š์€ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ๊ณผ ์ฝ˜๋“œ๋กœ์ด์นœ ํ™ฉ์‚ฐ์—ผ์˜ ์กฐํ•ฉ์ด๋‚˜ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์„ ๋ฉ”ํ‹ธ์„คํฌ๋‹๋ฉ”ํƒ„(Methylsulfonylmethane)๊ณผ ํ•จ๊ป˜ ์‚ฌ์šฉํ•˜๋ฉด ๋”์šฑ ์œ ์ตํ•œ ํšจ๊ณผ๋ฅผ ์–ป์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ, ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ๊ณผ ํ•จ๊ป˜ ๋ฉ”ํ‹ธ์„คํฌ๋‹๋ฉ”ํƒ„์„ ์‚ฌ์šฉํ•˜๋ฉด ํ•„์ˆ˜์ ์ธ ํ™ฉ์ด ๊ณต๊ธ‰๋˜๋ฏ€๋กœ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ์—ผ์‚ฐ์—ผ์˜ ํšจ๋Šฅ์ด ํ–ฅ์ƒ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ™ฉ์€ ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์˜ ์น˜๋ฃŒ ํšจ๊ณผ์— ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๊ธฐ ๋•Œ๋ฌธ์— ํ™ฉ์„ ๋‹ค๋ฅธ ์„ฑ๋ถ„์œผ๋กœ ๋Œ€์ฒดํ•˜๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ๋ณด์ถฉ์ œ์˜ ํšจ๋Šฅ์ด ์ €ํ•˜๋  ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์Šต๋‹ˆ๋‹ค. ํ™ฉ์€ ์—ฐ๊ณจ, ํž˜์ค„, ์ธ๋Œ€์˜ ๊ฒฐํ•ฉ์กฐ์ง ๊ธฐ์งˆ์„ ์•ˆ์ •์‹œํ‚ค๊ธฐ ๋•Œ๋ฌธ์— ๊ด€์ ˆ ์กฐ์ง์— ํ•„์ˆ˜์ ์ž…๋‹ˆ๋‹ค. ๋˜ํ•œ ์—ฐ๊ณจ ํ‡ดํ–‰์„ ๋ฐฉ์ง€ํ•˜๋Š” ๋ฐ๋„ ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค. ๋”ฐ๋ผ์„œ ๊ธ€๋ฆฌ์ฝ”์‚ฌ๋ฏธ๋…ธ๊ธ€๋ฆฌ์นธ์˜ ํ™ฉ ํ•จ๋Ÿ‰์„ ์ ์ ˆํ•œ ์ˆ˜์ค€์œผ๋กœ ์œ ์ง€ํ•˜๋Š” ๊ฒƒ์€ ์—ฐ๊ณจ ์•…ํ™”๋ฅผ ์˜ˆ๋ฐฉํ•˜๋Š” ๋ฐ ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค.

๊ฒฐ๋ก 

์ข…ํ•ฉ์ ์œผ๋กœ ๋ณผ ๋•Œ, ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ ํ™ฉ์‚ฐ์—ผ์— ๋Œ€ํ•œ ๊ด‘๋ฒ”์œ„ํ•œ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ์— ๋”ฐ๋ฅด๋ฉด ๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ์€ ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ์ง€์›ํ•˜๊ณ  ์ „๋ฐ˜์ ์ธ ์›ฐ๋น™์„ ์ฆ์ง„ํ•˜๋Š” ๋ฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ์ˆ˜ํ–‰ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

์ฐธ๊ณ ๋ฌธํ—Œ:

  1. Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Res Ther. 2012 Jan 30;14(1):201.
  2. Herrero-Beaumont G, Largo R. Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation? Ann Rheum Dis. 2020 Oct;79(10):1261-1263.
  3. Conrozier T, Lohse T. Glucosamine as a Treatment for Osteoarthritis: What If It's True? Front Pharmacol. 2022 Mar 17;13:820971. 
  4. Knapik JJ, Pope R, Hoedebecke SS, et al. Effects of Oral Glucosamine Sulfate on Osteoarthritis-Related Pain and Joint-Space Changes: Systematic Review and Meta-Analysis. J Spec Oper Med. 2018 Winter;18(4):139-147.
  5. Bruyรจre O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3):337-350.
  6. Knapik JJ, Pope R, Hoedebecke SS, Schram B, Orr R, Lieberman HR. Effects of Oral Glucosamine Sulfate on Osteoarthritis-Related Pain and Joint-Space Changes: Systematic Review and Meta-Analysis. J Spec Oper Med. 2018 Winter;18(4):139-147.
  7. Setnikar I, Palumbo R, Canali S, et al. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43:1109โ€“1113.
  8. Zhu X, Sang L, Wu D, et al. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2018 Jul 6;13(1):170. 
  9. Meng Z, Liu J, Zhou N. Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2023 Jan;143(1):409-421.
  10. Simental-Mendรญa M, Sรกnchez-Garcรญa A, Vilchez-Cavazos F, et al. Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials. Rheumatol Int. 2018 Jun 11. doi: 10.1007/s00296-018-4077-2.
  11. Lubis AMT, Siagian C, Wonggokusuma E, Marsetyo AF, Setyohadi B. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial. Acta Med Indones. 2017 Apr;49(2):105-111.
  12. Nunes RM, Girรฃo VCC, Cunha PLR, et al. Decreased Sulfate Content and Zeta Potential Distinguish Glycosaminoglycans of the Extracellular Matrix of Osteoarthritis Cartilage. Front Med (Lausanne). 2021 Apr 29;8:612370.
  13. Houpt J.B, McMillan R, Wein C, et al. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999;26:2423โ€“2430.
  14. Sawitzke A.D, Shi H, Finco M.F, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008;58:3183โ€“3191.
  15. Sawitzke A.D, Shi H, Finco M.F, et al. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis 2010;69:1459โ€“1464.
  16. Capps JC, Shetlar MR, Bradford RH. Hexosamine metabolism. I. The absorption and metabolism, in vivo, of orally administered D-glucosamine and N-acetyl-D-glucosamine in the rat. Biochim Biophys Acta 1966;127194โ€“204.
  17. Tesoriere G, Dones F, Magistro; et al. Intestinal absorption of glucosamine and N-acetylglucosamine. Experientia 1972;28 770โ€“771.
  18. Bruyere O, Pavelka K, Rovati LC, et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 2004;11:138โ€“143.
  19. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251โ€“256.
  20. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162:2113โ€“2123.
  21. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 2008;16;254โ€“260.
  22. Bruyere O, Honore A, Ethgen O, et al. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 2003;1:1โ€“5.
  23. Nagaoka I, Tsuruta A, Yoshimura M. Chondroprotective action of glucosamine, a chitosan monomer, on the joint health of athletes. Int J Biol Macromol. 2019 Jul 1;132:795-800.
  24. Yoshimura M, Sakamoto K, Tsuruta A, et al. Evaluation of the effect of glucosamine administration on biomarkers for cartilage and bone metabolism in soccer players. Int J Mol Med 2009;24:487โ€“494.